DR. AJIT SOOD
PROFESSOR & HEAD
Medical Gastroenterology
MBBS, MD (Medicine), DM (Gastroenterology)
PMC-21250
About Doctor
Professor Ajit Sood is an eminent gastroenterologist and academic, currently serving as Professor and Head of the Department of Gastroenterology at Dayanand Medical College & Hospital, Ludhiana. With over 40 years of medical experience, he is nationally and internationally recognized for his pioneering work in inflammatory bowel disease (IBD), celiac disease, and hepatitis C.
He was the first to establish the epidemiology of ulcerative colitis in India and has led groundbreaking genetic and microbiome studies, including India's first GWAS on IBD. His work has been published in leading journals like Gut, Nature Genetics, and the Journal of Crohn’s and Colitis. He has also been a key figure in introducing fecal microbiota transplantation (FMT) for ulcerative colitis in India.
Professor Sood is the founder of the Colitis and Crohn’s Foundation (India) and the Digestive Diseases Care Foundation, both of which focus on education, patient care, and public health outreach. He has received numerous honors, including the Dr. B. C. Roy National Award and several national orations.
With over 13,000 citations and an h-index of 45, Professor Sood remains a leading voice in gastroenterology, committed to advancing clinical care, research, and training.
Specialization and Expertise
OPD Timings
Certifications
Journal Positions
- Member, Editorial Board, Indian Journal of Gastroenterology
- Member, Editorial Board, Intestinal Research
- Member, Editorial Board, Journal of Clinical and Experimental Hepatology
- Reviewer for numerous international and national peer-reviewed journals
Affiliations to International/National Committees/Organizations
- Member, Gastro 2009 Working Group on Biological Therapies in IBD, European Colitis Crohn’s Organization (ECCO)
- Core Committee Member on Practice Guidelines for IBD Management, World Gastroenterology Organization
- India Representative, Asian Organization for Crohn’s and Colitis (AOCC)
- Member, International Celiac Disease Consortium
- Member, Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP)
- Member, Indian Council of Medical Research (ICMR) Task Force for Celiac Disease
- Member, Indian Society of Gastroenterology Task Forces on IBD, Hepatitis B and C, IBS, and GERD
Publications
Singh A, Bhardwaj A, Sharma R, Midha V, Sood A. Developing IBD counsellors in low- and middle-income countries: bridging gaps in patient care. EClinicalMedicine. 2025 Apr 24;83:103218.
Singh A, Bhardwaj A, Sharma R, Jain D, Midha V, Sood A. Effectiveness and Safety of Tofacitinib in Biologic-naïve Elderly Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2025 Apr 15:S1542-3565(25)00292-7.
Singh A, Midha V, Sood A. Perspectives on the International Consensus for Acute Severe Ulcerative Colitis Clinical Trial Design: Enhancing Clarity and Applicability. Clin Gastroenterol Hepatol. 2025 Mar 13:S1542-3565(25)00191-0.
Kakkar C, Bonaffini PA, Singh A, Narang V, Mahajan R, Verma S, Singla S, Sood A. MR enterography in Crohns disease and beyond: a pictorial review : Beyond Crohn's: a pictorial guide to MR enterography in small bowel disease. Abdom Radiol (NY). 2025 Feb 3.
Sebastian S, Ahuja V, Sood A. Putting the best foot forward: rethinking the paradigms in ASUC. Gut. 2025 Feb 11:gutjnl-2024-334267.
Singh A, Midha V, Kochhar GS, Shen B, Sood A. Management of Perianal Fistulizing Crohn's Disease. Inflamm Bowel Dis. 2024 Sep 3;30(9):1579-1603.
Singh A, Goyal MK, Midha V, Mahajan R, Kaur K, Gupta YK, Singh D, Bansal N, Kaur R, Kalra S, Goyal O, Mehta V, Sood A. Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial. Am J Gastroenterol. 2024 Jul 1;119(7):1365-1372.
Singh A, Midha V, Sood A. Low risk of malignancies with thiopurines in an Indian cohort of patients with Inflammatory bowel disease. Indian J Gastroenterol. 2024 Jun 14.
Singh A, Mahajan R, Midha V, Kaur K, Singh D, Kaur R, Garg S, Arora K, Bansal N, Sood A. Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis. Dig Dis Sci. 2024 Apr;69(4):1389-1402.
Vieujean S, Lindsay JO, D'Amico F, Ahuja V, Silverberg MS, Sood A, Yamamoto-Furusho JK, Nagahori M, Watanabe M, Koutroubakis IE, Foteinogiannopoulou K, Avni Biron I, Walsh A, Outtier A, Nordestgaard RLM, Abreu MT, Dubinsky M, Siegel C, Louis E, Dotan I, Reinisch W, Danese S, Rubin DT, Peyrin-Biroulet L. Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD. J Crohns Colitis. 2024 Apr 23;18(4):548-559.
Awards
Awards and Orations
- Fellow, Indian College of Physicians
- Fellow, International Medical Sciences Academy
- Dr. B. C. Roy National Award in Research, 2003
- Sat Paul Mittal Award of Appreciation, 2019, Nehru Sidhant Kender Trust
- Dr. B. C. Bansal & Uma Bansal Oration, 2004, Indian Academy of Clinical Medicine
- Astra Zeneca Oration, ISG Conference, October 2008, Delhi
- SL Bose Oration, “IBD in India: Are We Any Different from the West?” August 2008
- Zydus-Alidac Oration, Indian Society of Gastroenterology, 2011
- Excellence Award in Gastroenterology, Indian Medical Association and Indian Academy of Medical Specialties
- Certificate of Appreciation, Dayanand Medical College & Hospital Founder’s Day
- Economic Forum 2018 Awards, Most Inspiring Doctor
- BMJ Awards 2018 Finalist, Infectious Disease Category
- Dr. C. M. Habibullah Distinguished Researcher Oration, Indian Society of Gastroenterology, 2021
Dayanand Medical College & Hospital
.webp)
.webp)
Enter at least 2 characters...
Enter at least 2 characters...
Enter at least 2 characters...
Enter at least 2 characters...
Enter at least 2 characters...